EX-PO Trial : Evaluation of the Occlusion Pressure (PO.1) in Extubation Failure
NCT ID: NCT04654273
Last Updated: 2021-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
152 participants
OBSERVATIONAL
2020-11-30
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of ExPreS in the Weaning of Patients in Invasive Mechanical Ventilation
NCT05085457
Atelectasis Formation: Role of Positive Pressure Breathing, Hyperoxia, and Hypobaria
NCT03311347
ONE-HOUR POSITIVE PRESSURE VENTILATION AFTER A PRESSURE SUPPORT SPONTANEOUS BREATHING TRIAL: A RANDOMIZED CLINICAL TRIAL
NCT07324460
End-eXpiratory Occlusion Test to Predict fluId REsponsiveness in the Operating Room (EXPIRE)
NCT04399278
Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial
NCT03861117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in surgical or neurosurgical intensive care units
* Patients under mechanical ventilation for more than 48 hours,
* Meeting the criteria for severability (spontaneous ventilation test),
* Free subject, without tutorship or curatorship or subordination,
* Patients benefiting from a Social Security scheme or benefiting through the intermediary of a third party,
* No objection given by the patient and / or relative after clear and fair information about the study.
Exclusion Criteria
* Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, adults under legal protection,
* Pregnant and / or lactating women.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU POitiers
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Damien Marie, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-PO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.